The reduction of post-partum morbidity by the prophylactic use of ergonovine
- 1 July 1940
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 40 (1) , 111-117
- https://doi.org/10.1016/s0002-9378(40)91125-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical experiences with ergonovineAmerican Journal of Obstetrics and Gynecology, 1938
- THE PRESENT STATUS OF OXYTOCICS IN OBSTETRICSJAMA, 1936
- Prophylactic use of ergot and ergotamine tartrate in puerperiumThe American Journal of Surgery, 1936
- Council on Pharmacy and ChemistryJAMA, 1936
- THE SUBSTANCE RESPONSIBLE FOR THE TRADITIONAL CLINICAL EFFECT OF ERGOTBMJ, 1935
- Intestinal Complications Resulting from Prolonged Radium and X-Ray Irradiation for Malignant Conditions of the Pelvic OrgansAmerican Journal of Obstetrics and Gynecology, 1935
- Ergot and ergotamine tartrate in puerperal prophylaxisAmerican Journal of Obstetrics and Gynecology, 1935
- A New Active Principle in Ergot and its Effects on Uterine MotilityAmerican Journal of Obstetrics and Gynecology, 1935
- The Essentials of Postpartum CareNew England Journal of Medicine, 1931
- The Dosage and Action of Pituitary Extract and of the Ergot Alkaloids on the Uterus in Labour, with a note on the Action of Adrenalin.*BJOG: An International Journal of Obstetrics and Gynaecology, 1927